Prescription drug spend represented 13.7% of national health expenditures in 2018, totaling $500 billion, and is...

The 2021 audit cycle is coming to a close. The Centers for Medicare and Medicaid Services (CMS) issued its last...

From development of a medication for treatment-resistant HIV with a novel mechanism of action to approval of...

The pandemic continues to have a profound impact on healthcare and that includes the Centers for Medicare and...

Recent attention has been given to rare or orphan diseases—more specifically, to the costs associated with the drugs...

America has been in the throes of an opioid epidemic since the late ‘90s, with half a million people dying of opioid...

Alzheimer’s is a devastating and deadly disease that affects an estimated 6.5 million Americans age 65 and older, or...

With kids heading back to school, the days growing shorter and the nights getting cooler, it can only mean one...

The pandemic had a dramatic impact on the American workforce with millions of workers becoming remote employees...

On May 14, 2021, the Centers for Medicare and Medicaid Services (CMS) released the “2020 Part C and Part D Program...